Sepracor Inc
Could not find a ticker for this position, may be a filing error
Research-based pharmaceutical company developing and commercializing products for respiratory and central nervous system disorders
SDCV 5.000% convertible note due 2/1 (debt instrument)
No Schedule 13D or 13G filings recorded.